Optimal therapeutic adropin dose intervention in mice and rat animal models: A systematic review
Background and Aim: Adropin is a hormone encoded by the Enho gene, which is associated with energy homeostasis. Preclinical studies using animal models have shown that adropin plays a role in enhancing glucose homeostasis and dyslipidemia. Lately, several studies on animal models have been performed...
Main Authors: | Foad Alzoughool, Mohammad Borhan Al-Zghoul |
---|---|
Format: | Article |
Language: | English |
Published: |
Veterinary World
2021-06-01
|
Series: | Veterinary World |
Subjects: | |
Online Access: | http://www.veterinaryworld.org/Vol.14/June-2021/4.pdf |
Similar Items
-
The optimal therapeutic irisin dose intervention in animal model: A systematic review
by: Foad Alzoughool, et al.
Published: (2020-10-01) -
Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article
by: Somaye YOSAEE, et al.
Published: (2016-12-01) -
Adropin reduces blood glucose levels in mice by limiting hepatic glucose production
by: Dharendra Thapa, et al.
Published: (2019-04-01) -
The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia
by: Raziye Akcılar, et al.
Published: (2016-03-01) -
Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance
by: Su Gao, et al.
Published: (2015-04-01)